1001 Sherbrooke St. W
Montreal
Canada
McGill University
hematologic malignancies, COVID-19 vaccination, fourth and subsequent COVID-19 vaccines
myeloma, plasma cell dyscrasias, BCL2 inhibitor
Multiple myeloma, autologous stem cell transplantation, ASCT2, Maintenance Therapy